GET THE APP

Ovarian Remnant Syndrome and its Implications in a Brca1 Positive Patient

Clinical Oncology: Case Reports.

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Ovarian Remnant Syndrome and its Implications in a Brca1 Positive Patient

Presentation: A 44 year old Caucasian female with a BRCA1 variant c.3598C>T (p.Q1200X) mutation carrier was referred to the cancer genetics services to discuss risk reduction.

Treatment: She opted for risk reducing prophylactic bilateral salpingo-oophorectomy. Despite the initial procedure she continued to menstruate and underwent two further procedures to remove remnant ovarian tissue.

Diagnosis: Ovarian remnant syndrome

Discussion: Despite risk reducing salpingo-oophorectomy some patients still develop ovarian cancer. In BRCA1 mutation carriers, bilateral salpingo-oophorectomy is associated with a 70% reduction in risk of ovarian cancer in women without a prior breast cancer and 85% in those with a prior breast cancer. It is possible that remnant ovarian tissue could account for some of these cases of ovarian cancer after risk reducing surgery.

Special Features

Full Text

View

Track Your Manuscript

Media Partners

Associations